Back to Search
JEFFREY JANKUN, M.D.
M.D.
Anesthesiology Physician
NPI: 1821045519IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
155072(MA)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
BOSTON UNIVERSITY SCHOOL OF MEDICINE
Class of 1993
Research & Publications (20)
VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form.
PMID 19082507·Int J Mol Med·2009
7-preclinical
Human platelet 12-lipoxygenase, new findings about its activity, membrane binding and low-resolution structure.
PMID 18155727·J Mol Biol·2008
8-other
Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
PMID 17912461·Int J Mol Med·2007
8-other
PAI-1 induces cell detachment, downregulates nucleophosmin (B23) and fortilin (TCTP) in LnCAP prostate cancer cells.
PMID 17549383·Int J Mol Med·2007
4-observational
Plasminogen activator inhibitor-1 is locked in active conformation and polymerizes upon binding ligands neutralizing its activity.
PMID 16465390·Int J Mol Med·2006
8-other
Nutraceutical inhibitors of urokinase: potential applications in prostate cancer prevention and treatment.
PMID 16820913·Oncol Rep·2006
8-other
Effect of crystal freezing and small-molecule binding on internal cavity size in a large protein: X-ray and docking studies of lipoxygenase at ambient and low temperature at 2.0 A resolution.
PMID 16790932·Acta Crystallogr D Biol Crystallogr·2006
8-other
Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells.
PMID 16731771·Mol Cancer Ther·2006
7-preclinical
Vascular endothelial growth factor production in human prostate cancer cells is stimulated by overexpression of platelet 12-lipoxygenase.
PMID 16482570·Prostate·2006
8-other
In vivo and in vitro effect of baicalein on human prostate cancer cells.
PMID 15586246·Int J Oncol·2005
7-preclinical
Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy.
PMID 15892808·BJU Int·2005
7-preclinical
Aspirin blocks binding of photosensitizer SnET2 into human serum albumin: implications for photodynamic therapy.
PMID 15806298·Int J Mol Med·2005
8-other
Plasminogen activator inhibitor type-1 controls the process of the in vitro sprout formation.
PMID 15611593·J Physiol Pharmacol·2004
8-other
Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.
PMID 15547731·Oncol Rep·2004
4-observational
Transperineal in vivo fluence-rate dosimetry in the canine prostate during SnET2-mediated PDT.
PMID 15357193·Phys Med Biol·2004
7-preclinical
Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapy.
PMID 15247773·J Urol·2004
7-preclinical
Plasminogen activator inhibitor type-1: its structure, biological activity and role in tumorigenesis (Review).
PMID 15138609·Int J Mol Med·2004
6-review
Soybean lipoxygenase-3 in complex with 4-nitrocatechol.
PMID 14993710·Acta Crystallogr D Biol Crystallogr·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 330 BROOKLINE AVE
BOSTON, MA 02215 - Phone
- (617) 754-2675
Quick Facts
- NPI
- 1821045519
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile